Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy. (2022). Reumatismo, 74(3). https://doi.org/10.4081/reumatismo.2022.1511